Cargando…

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

Background: The aim of our study was to assess if patients with AF (atrial fibrillation) and a history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K antagonist oral anticoagulants). Methods: The Polish AF (POL-AF) registry is a prospective, observational, multicen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szyszkowska, Anna, Kuźma, Łukasz, Wożakowska-Kapłon, Beata, Gorczyca-Głowacka, Iwona, Jelonek, Olga, Uziębło-Życzkowska, Beata, Krzesiński, Paweł, Wójcik, Maciej, Błaszczyk, Robert, Gawałko, Monika, Kapłon-Cieślicka, Agnieszka, Tokarek, Tomasz, Rajtar-Salwa, Renata, Bil, Jacek, Wojewódzki, Michał, Szpotowicz, Anna, Krzciuk, Małgorzata, Bednarski, Janusz, Bakuła, Elwira, Wełnicki, Marcin, Mamcarz, Artur, Tomaszuk-Kazberuk, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564626/ https://www.ncbi.nlm.nih.gov/pubmed/36231257 http://dx.doi.org/10.3390/ijerph191911939

Ejemplares similares

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry
por: Kiliszek, Marek, et al.
Publicado: (2021)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szpotowicz, Anna, et al.
Publicado: (2021)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
por: Gawałko, Monika, et al.
Publicado: (2021)

Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study
por: Wełnicki, Marcin, et al.
Publicado: (2021)

Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort
por: Wełnicki, Marcin, et al.
Publicado: (2022)

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardiography in patients treated with non-vitamin K antagonist oral anticoagulants: Multicenter experience
por: Gorczyca, Iwona, et al.
Publicado: (2023)

Risk of left atrial appendage thrombus in older patients with atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2021)

Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease
por: Budnik, Monika, et al.
Publicado: (2022)

Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation
por: Uziębło-Życzkowska, Beata, et al.
Publicado: (2020)

Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs
por: Bielecka, Bernadetta, et al.
Publicado: (2022)

Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Does the CHA(2)DS(2)-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
por: Michalska, Anna, et al.
Publicado: (2020)

Risk factors for left atrial thrombus in younger patients (aged < 65 years) with atrial fibrillation or atrial flutter: Data from the multicenter left atrial thrombus on transesophageal echocardiography (LATTEE) registry
por: Uziȩbło-Życzkowska, Beata, et al.
Publicado: (2022)

Increased Body Mass Index and Risk of Left Atrial Thrombus in Nonvalvular Atrial Fibrillation Patients—Data from the Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) Registry
por: Uziębło-Życzkowska, Beata, et al.
Publicado: (2022)

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter
por: Wybraniec, Maciej T., et al.
Publicado: (2022)

Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry
por: Kapłon-Cieślicka, Agnieszka, et al.
Publicado: (2022)

Pharmacotherapy of atrial fibrillation in COVID-19 patients
por: Tomaszuk-Kazberuk, Anna, et al.
Publicado: (2021)

Value of Left Atrial Strain in Predicting Recurrence after Atrial Fibrillation Ablation
por: Kiliszek, Marek, et al.
Publicado: (2023)

Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Echocardiographic predictors of thrombus in left atrial appendage—The role of novel transthoracic parameters
por: Kaufmann, Damian, et al.
Publicado: (2022)

Is transesophageal echocardiography necessary before electrical cardioversion in patients treated with non-vitamin K antagonist oral anticoagulants? Current evidence and practical approach
por: Gorczyca, Iwona, et al.
Publicado: (2023)

Left Atrial Wall Motion Velocity Assessed during Atrial Fibrillation Predicts Sinus Rhythm Maintenance after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation
por: Wałek, Paweł, et al.
Publicado: (2022)

New oral anticoagulants – will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome?
por: Gorczyca-Michta, Iwona, et al.
Publicado: (2013)

Echocardiographic Evaluation of Atrial Remodelling for the Prognosis of Maintaining Sinus Rhythm after Electrical Cardioversion in Patients with Atrial Fibrillation
por: Wałek, Paweł, et al.
Publicado: (2023)

Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients
por: Wożakowska-Kapłon, Beata, et al.
Publicado: (2010)

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
por: Gawałko, Monika, et al.
Publicado: (2020)

Long-Term Outcomes after Stroke in Patients with Atrial Fibrillation: A Single Center Study
por: Tracz, Justyna, et al.
Publicado: (2023)

Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention
por: Gorczyca, Iwona, et al.
Publicado: (2019)

The Importance of a Distance between the Lines Encircling Pulmonary Veins in Atrial Fibrillation Ablation on First-Pass Isolation Ratio and Clinical Outcomes
por: Krzyżanowski, Krystian, et al.
Publicado: (2023)

Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation
por: Wałek, Paweł, et al.
Publicado: (2021)

Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019
por: Gorczyca-Głowacka, Iwona, et al.
Publicado: (2022)

Trends in Stroke Prevention between 2014 and 2018 in Hospitalized Atrial Fibrillation Patients
por: Bielecka, B., et al.
Publicado: (2021)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Erratum to: NOACs for secondary stroke prevention in patients with atrial fibrillation
Publicado: (2020)

Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
por: Bielecka, Bernadetta, et al.
Publicado: (2023)

Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project
por: Kuźma, Łukasz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pp96je46oam8u97of8h0hh9nd4